Larry Biegelsen
Stock Analyst at Wells Fargo
(2.95)
# 2,581
Out of 4,382 analysts
1279
Total ratings
48.6%
Success rate
1.2%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintained: Hold | $82 → $66 | $67.34 | -1.99% | 43 | Jun 5, 2026 | |
| MDT Medtronic | Rated: Buy | $114 → $102 | $81.67 | +24.89% | 84 | Jun 4, 2026 | |
| MMED MiniMed Group | Rated: Buy | $26 → $22 | $14.23 | +54.60% | 2 | Jun 4, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $109 | $91.07 | +19.69% | 107 | Jun 1, 2026 | |
| DXCM DexCom | Rated: Buy | $85 | $72.86 | +16.66% | 61 | Jun 1, 2026 | |
| ZBH Zimmer Biomet Holdings | Rated: Hold | $90 | $87.33 | +3.06% | 42 | Jun 1, 2026 | |
| TNDM Tandem Diabetes Care | Upgraded: Buy | $21 → $27 | $19.34 | +39.61% | 31 | Jun 1, 2026 | |
| AVR Anteris Technologies Global | Rated: Buy | $16 | $9.64 | +65.98% | 3 | Jun 1, 2026 | |
| BSX Boston Scientific | Downgraded: Hold | $75 → $55 | $48.55 | +13.29% | 50 | May 28, 2026 | |
| PODD Insulet | Maintained: Buy | $255 | $153.22 | +66.43% | 38 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $654 | $422.06 | +54.95% | 59 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $19 | $15.74 | +20.71% | 12 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $135 → $138 | $125.00 | +10.40% | 54 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 | $81.01 | -13.59% | 3 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 → $37 | $28.10 | +31.67% | 3 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $40 | $23.78 | +68.21% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $116 → $138 | $129.84 | +6.28% | 20 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $104 → $103 | $80.00 | +28.75% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $15 | $16.99 | -11.71% | 13 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 → $56 | $41.19 | +35.96% | 37 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 → $17 | $17.16 | -0.93% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $78 → $74 | $64.48 | +14.76% | 42 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $456 → $418 | $305.66 | +36.75% | 38 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $48 | $42.80 | +12.15% | 2 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $240 → $263 | $232.77 | +12.99% | 94 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $8.00 | +250.00% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $42 | $35.16 | +19.45% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $180 | $178.82 | +0.66% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | CHF 69.82 → CHF 76.96 | $53.12 | +44.88% | 33 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $80 → $84 | $91.98 | -8.68% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $18 | $15.46 | +16.43% | 57 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $100 | $85.96 | +16.33% | 65 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $184 → $157 | $151.16 | +3.86% | 40 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $97 | $64.67 | +49.99% | 26 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $280 → $270 | $196.04 | +37.73% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 → $374 | $320.53 | +16.68% | 46 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $19.41 | +44.29% | 5 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $19 | $19.38 | -1.96% | 36 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $13 | $5.00 | +160.00% | 24 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $1.53 | +96.08% | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.38 | - | 15 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $100.98 | n/a | 3 | Aug 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $1.4 | $7.35 | n/a | 3 | Sep 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $149.16 | n/a | 1 | Jan 4, 2010 |
The Cooper Companies
Jun 5, 2026
Maintained: Hold
Price Target: $82 → $66
Current: $67.34
Upside: -1.99%
Medtronic
Jun 4, 2026
Rated: Buy
Price Target: $114 → $102
Current: $81.67
Upside: +24.89%
MiniMed Group
Jun 4, 2026
Rated: Buy
Price Target: $26 → $22
Current: $14.23
Upside: +54.60%
Abbott Laboratories
Jun 1, 2026
Maintained: Buy
Price Target: $109
Current: $91.07
Upside: +19.69%
DexCom
Jun 1, 2026
Rated: Buy
Price Target: $85
Current: $72.86
Upside: +16.66%
Zimmer Biomet Holdings
Jun 1, 2026
Rated: Hold
Price Target: $90
Current: $87.33
Upside: +3.06%
Tandem Diabetes Care
Jun 1, 2026
Upgraded: Buy
Price Target: $21 → $27
Current: $19.34
Upside: +39.61%
Anteris Technologies Global
Jun 1, 2026
Rated: Buy
Price Target: $16
Current: $9.64
Upside: +65.98%
Boston Scientific
May 28, 2026
Downgraded: Hold
Price Target: $75 → $55
Current: $48.55
Upside: +13.29%
Insulet
May 28, 2026
Maintained: Buy
Price Target: $255
Current: $153.22
Upside: +66.43%
May 28, 2026
Maintained: Buy
Price Target: $654
Current: $422.06
Upside: +54.95%
May 27, 2026
Rated: Buy
Price Target: $19
Current: $15.74
Upside: +20.71%
May 22, 2026
Rated: Buy
Price Target: $135 → $138
Current: $125.00
Upside: +10.40%
May 22, 2026
Maintained: Hold
Price Target: $70
Current: $81.01
Upside: -13.59%
May 15, 2026
Rated: Buy
Price Target: $35 → $37
Current: $28.10
Upside: +31.67%
May 8, 2026
Maintained: Buy
Price Target: $42 → $40
Current: $23.78
Upside: +68.21%
May 8, 2026
Maintained: Hold
Price Target: $116 → $138
Current: $129.84
Upside: +6.28%
May 8, 2026
Maintained: Buy
Price Target: $104 → $103
Current: $80.00
Upside: +28.75%
May 6, 2026
Maintained: Hold
Price Target: $12 → $15
Current: $16.99
Upside: -11.71%
May 5, 2026
Maintained: Hold
Price Target: $70 → $56
Current: $41.19
Upside: +35.96%
May 4, 2026
Rated: Hold
Price Target: $14 → $17
Current: $17.16
Upside: -0.93%
May 1, 2026
Maintained: Hold
Price Target: $78 → $74
Current: $64.48
Upside: +14.76%
May 1, 2026
Maintained: Buy
Price Target: $456 → $418
Current: $305.66
Upside: +36.75%
Apr 29, 2026
Maintained: Buy
Price Target: $40 → $48
Current: $42.80
Upside: +12.15%
Apr 15, 2026
Rated: Buy
Price Target: $240 → $263
Current: $232.77
Upside: +12.99%
Mar 17, 2026
Maintained: Buy
Price Target: $28
Current: $8.00
Upside: +250.00%
Mar 17, 2026
Maintained: Hold
Price Target: $42
Current: $35.16
Upside: +19.45%
Mar 17, 2026
Maintained: Hold
Price Target: $180
Current: $178.82
Upside: +0.66%
Feb 26, 2026
Upgraded: Buy
Price Target: CHF 69.82 → CHF 76.96
Current: $53.12
Upside: +44.88%
Feb 20, 2026
Maintained: Hold
Price Target: $80 → $84
Current: $91.98
Upside: -8.68%
Feb 19, 2026
Maintained: Hold
Price Target: $17 → $18
Current: $15.46
Upside: +16.43%
Feb 11, 2026
Reiterated: Buy
Price Target: $96 → $100
Current: $85.96
Upside: +16.33%
Feb 10, 2026
Maintained: Hold
Price Target: $184 → $157
Current: $151.16
Upside: +3.86%
Feb 5, 2026
Maintained: Buy
Price Target: $95 → $97
Current: $64.67
Upside: +49.99%
Jan 30, 2026
Maintained: Hold
Price Target: $280 → $270
Current: $196.04
Upside: +37.73%
Jan 16, 2026
Downgraded: Hold
Price Target: $330 → $374
Current: $320.53
Upside: +16.68%
Jan 14, 2026
Maintained: Buy
Price Target: $28
Current: $19.41
Upside: +44.29%
Dec 12, 2025
Maintained: Hold
Price Target: $24 → $19
Current: $19.38
Upside: -1.96%
Dec 12, 2025
Maintained: Hold
Price Target: $9 → $13
Current: $5.00
Upside: +160.00%
Nov 13, 2025
Maintained: Hold
Price Target: $3
Current: $1.53
Upside: +96.08%
Oct 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.38
Upside: -
Aug 2, 2018
Reiterated: Buy
Price Target: $26 → $20
Current: $100.98
Upside: n/a
Sep 26, 2013
Downgraded: Hold
Price Target: $15 → $1.4
Current: $7.35
Upside: n/a
Jan 4, 2010
Upgraded: Buy
Price Target: n/a
Current: $149.16
Upside: n/a